A comparison of the pharmacokinetics and pharmacodynamics of cilazapril between Chinese and Caucasian healthy, normotensive volunteers

[1]  B. Tomlinson,et al.  Comparison of the pharmacokinetics and pharmacodynamics of oral doses of perindopril in normotensive Chinese and Caucasian volunteers. , 1995, British journal of clinical pharmacology.

[2]  E. Lee,et al.  Population genetics of the angiotensin-converting enzyme in Chinese. , 1994, British journal of clinical pharmacology.

[3]  J. Chen,et al.  The Chinese total diet study in 1990. Part II. Nutrients. , 1993, Journal of AOAC International.

[4]  J. Chan,et al.  Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis. , 1992, BMJ.

[5]  R. Swaminathan,et al.  Blood pressure and urinary cations in a Chinese population. , 1992, Journal of human hypertension.

[6]  C. Richard,et al.  Angiotensin converting enzyme inhibition. Systemic and regional hemodynamics in rats and humans. , 1991, American journal of hypertension.

[7]  Y. Yamori,et al.  Relationship Between Dietary Factors and Blood Pressure in China , 1990 .

[8]  J. Mcewen,et al.  The pharmacokinetics and bioavailability of cilazapril in normal man. , 1989, British journal of clinical pharmacology.

[9]  J. Reid,et al.  The influence of cilazapril on indices of autonomic function in normotensives and hypertensives. , 1989, British journal of clinical pharmacology.

[10]  G R Wilkinson,et al.  Racial differences in drug response. Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites. , 1989, The New England journal of medicine.

[11]  Liubimova Ls,et al.  Urinary cations and blood pressure: a collaborative study of 16 districts in China , 1988 .

[12]  L. Liu,et al.  Urinary cations and blood pressure: a collaborative study of 16 districts in China. , 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[13]  J. Webster.  Angiotensin converting enzyme inhibitors in the clinic: first-dose hypotension. , 1987, Journal of Hypertension - Supplement.

[14]  Seedat Yk,et al.  A comparison of lisinopril and atenolol in black and Indian patients with mild-to-moderate essential hypertension. , 1987 .

[15]  B. Waeber,et al.  Pharmacokinetics of the Converting Enzyme Inhibitor Cilazapril in Normal Volunteers and the Relationship to Enzyme Inhibition: Development of a Mathematical Model , 1987, Journal of Cardiovascular Pharmacology.

[16]  B. Waeber,et al.  Repeated Administration of the Converting Enzyme Inhibitor Cilazapril to Normal Volunteers , 1987, Journal of cardiovascular pharmacology.

[17]  B. Waeber,et al.  Effects of Single Doses of the Converting Enzyme Inhibitor Cilazapril in Normal Volunteers , 1987, Journal of cardiovascular pharmacology.

[18]  Y. Seedat,et al.  A comparison of lisinopril and atenolol in black and Indian patients with mild-to-moderate essential hypertension. , 1987, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[19]  W. Vetter,et al.  Highly sensitive microassay for aldosterone in unextracted plasma: comparison with two other methods. , 1984, The Journal of laboratory and clinical medicine.

[20]  B. Waeber,et al.  In-vitro response of plasma angiotensin converting enzyme to precursors and active forms of converting enzyme inhibitors , 1984 .

[21]  C. Venter,et al.  Ethnic differences in response to beta 1-adrenoceptor blockade by propranolol. , 1984, Journal of cardiovascular pharmacology.

[22]  J. Ryan,et al.  A simple radioassay for angiotensin-converting enzyme. , 1977, The Biochemical journal.

[23]  D W Cushman,et al.  Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. , 1971, Biochemical pharmacology.